Portfolio concentration
As of January 31, 2026 · N-PORT
Holdings
124
Top-10 weight
38.54%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
41
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
861.8
Holdings
As of January 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | BOSTON SCIENTIFIC CORP | — | 2,480,000 | $231.95M | 7.14% |
| 2 | LILLY ELI and CO | — | 202,000 | $209.50M | 6.45% |
| 3 | DANAHER CORP | — | 928,000 | $203.13M | 6.25% |
| 4 | JOHNSON&JOHNSON | — | 515,000 | $117.03M | 3.60% |
| 5 | Fidelity Securities Lending Cash Central Fund | — | 101,406,154 | $101.42M | 3.12% |
| 6 | ABBVIE INC | — | 440,000 | $98.12M | 3.02% |
| 7 | ARGENX SE SPONSORED ADR | — | 109,000 | $91.61M | 2.82% |
| 8 | UCB SA | — | 280,000 | $84.77M | 2.61% |
| 9 | Ascendis Pharma A/S | — | 370,000 | $83.66M | 2.57% |
| 10 | CVS HEALTH CORP | — | 950,000 | $70.79M | 2.18% |
| 11 | MASIMO CORP | — | 500,000 | $68.66M | 2.11% |
| 12 | EDWARDS LIFESCIENCES CORP | — | 828,000 | $67.37M | 2.07% |
| 13 | VEEVA SYSTEMS-A | — | 308,000 | $62.81M | 1.93% |
| 14 | THERMO FISHER SCIENTIFIC INC | — | 108,000 | $62.49M | 1.92% |
| 15 | ALNYLAM PHARMACEUTICALS INC | — | 167,000 | $56.46M | 1.74% |
| 16 | GILEAD SCIENCES INC | — | 390,000 | $55.36M | 1.70% |
| 17 | UNITEDHEALTH GRP | — | 180,000 | $51.65M | 1.59% |
| 18 | MERCK & CO | — | 460,000 | $50.72M | 1.56% |
| 19 | VIRIDIAN THERAPEUTICS INC | — | 1,500,000 | $49.50M | 1.52% |
| 20 | COGENT BIOSCIENCES INC | — | 1,360,000 | $48.84M | 1.50% |
| 21 | PENUMBRA INC | — | 130,000 | $46.56M | 1.43% |
| 22 | MODERNA INC | — | 1,020,000 | $44.95M | 1.38% |
| 23 | INSULET CORP | — | 174,000 | $44.51M | 1.37% |
| 24 | IQVIA HOLDINGS INC | — | 186,000 | $42.81M | 1.32% |
| 25 | BRIGHTSPRING HEALTH SERVICES INC | — | 1,080,000 | $42.41M | 1.30% |
| 26 | NUVALENT INC-A | — | 400,000 | $41.16M | 1.27% |
| 27 | INSMED INC | — | 250,000 | $39.22M | 1.21% |
| 28 | LEGEND BIOTECH CORP SPON ADR | — | 2,052,384 | $35.92M | 1.11% |
| 29 | CRINETICS PHARMACEUTICALS INC | — | 690,000 | $34.46M | 1.06% |
| 30 | ROCHE HOLDINGS AG (GENUSSCHEINE) | — | 75,000 | $34.11M | 1.05% |
| 31 | WAYSTAR HOLDING CORP | — | 1,280,000 | $34.00M | 1.05% |
| 32 | MCKESSON CORP | — | 40,000 | $33.25M | 1.02% |
| 33 | CARIS LIFE SCIENCES INC | — | 1,420,000 | $32.89M | 1.01% |
| 34 | ROYALTY PHARMA PLC | — | 760,000 | $31.68M | 0.97% |
| 35 | STRUCTURE THERAPEUTICS INC ADR | — | 350,000 | $30.96M | 0.95% |
| 36 | VAXCYTE INC | — | 560,000 | $30.00M | 0.92% |
| 37 | REPLIGEN CORP | — | 200,000 | $29.87M | 0.92% |
| 38 | STRYKER CORP | — | 80,000 | $29.56M | 0.91% |
| 39 | XENON PHARMACEUTICALS INC | — | 690,000 | $28.30M | 0.87% |
| 40 | DISC MEDICINE INC | — | 365,000 | $28.22M | 0.87% |
| 41 | PRIVIA HEALTH GROUP INC | — | 1,180,000 | $27.40M | 0.84% |
| 42 | INTUITIVE SURGICAL INC | — | 52,800 | $26.62M | 0.82% |
| 43 | PRAXIS PRECISION MEDICINES INC | — | 82,000 | $25.75M | 0.79% |
| 44 | ALIGNMENT HEALTHCARE INC | — | 1,120,000 | $25.23M | 0.78% |
| 45 | MEDLINE INC-A | — | 560,000 | $24.75M | 0.76% |
| 46 | BIONTECH SE ADR | — | 208,000 | $23.66M | 0.73% |
| 47 | CG ONCOLOGY INC | — | 428,000 | $22.28M | 0.69% |
| 48 | CENTESSA PHARMACEUTICALS LTD ADR | — | 850,000 | $20.88M | 0.64% |
| 49 | ORUKA THERAPEUTICS INC | — | 600,000 | $20.54M | 0.63% |
| 50 | 10X GENOMICS INC | — | 1,000,000 | $20.20M | 0.62% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.